Saturday, February 19, 2022

Second and third week of February 2022

We did not have time to update the blog last weekend so here round up 2 week's worth of events. Quite a lot happened in last two weeks. There were several dividend increases and dividend annoucements. 

Sampo's Board of Directors suggested 4,10 € dividend to AGM. This was a lot more than we expected. We expected 1,7 €. This dividend increase will mean approximately 700 € more dividends in 2022 than we estimated. 

Taaleri's Board of Directors suggested 1,2 € dividend to AGM. We did not have any expectations set for Taaleri so this will mean 272,40 € more dividends in 2022 than we expected. 

Aktia's Board of Directors dividend suggestion to AGM is 0,56 €. We expected to receive 0,43 € per share. This increase will have 10,27 € positive impact to our dividends in 2022. 

NN group increased dividend by 7% from 1,47 to 1,56. This means 4,21 € more dividends in 2022. 

Pepsico annouced dividend increase by 7%. This will increase our 2022 dividend approximately by 2 €

Genuine Parts announced 9,8% dividend hike. This will increase our 2022 dividends approximately by 1,40 €. 

Coca-Cola annouced dividend increase by 4,8%. This will increase our 2022 dividends approximately by 4 €.

In total the dividend hikes will increase our 2022 passive income by whopping 994,28 €. 

We received following dividends:

  • 19,33 € from Whitestone Reit
  • 37,88 € from Abbvie
  • 16,55 € from British American Tobacco
  • 0,89 € from Gladstone Investment Corp BDC
  • 8,32 € from Main Street Capital
  • 15,89 € from Exchange Income
  • 5,04 € from unknown source, last year's tax corrections. 
  • 22,99 € from Realty Income 
  • 50,00 € from Omega Healthcare Investors 
  • 0,80 € from Vodafone
  • 29 shares from Vodafone DRIP, worth 46,69 €
  • 1,49 € from Diversified Healthcare Trust

Total amount of dividends received was 225,87 €. The amount was very nice. As we have closed some positions which paid dividends in February we will not reach last year's February dividends.



No comments:

Post a Comment